Advertisement

Reinterventions for Thymoma Recurrences

  • Piero Zannini
  • Giampiero Negri
  • Monica Casiraghi
  • Luca Ferla
  • Paola Ciriaco

Abstract

Surgical resection is considered the gold standard for the treatment of thymomas no matter what the histological type. Even when complete resection is achieved, however, recurrence of thymoma is not uncommon as it occurs in about 10–29% of patients. Recurrences affect subsequent treatment and final outcome but there is still no general consensus on how to manage them. Complete resection of recurrences should be attempted whenever possible to achieve long-term survival. When complete resection is not feasible, an iterative debulking approach may improve survival by reducing the size of these slow-growing tumors. Currently, a multimodality approach combining radiotherapy and/or chemotherapy with surgery may be considered the best treatment for thymoma recurrences.

Keywords

Thymic Carcinoma Thymic Tumor Masaoka Stage Invasive Thymoma Decrease Recurrence Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wright CD, Wain JC, Mathisen DJ et al (2005) Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 130:1413–1421PubMedCrossRefGoogle Scholar
  2. 2.
    Chen G, Marx A, Wen-Hu C et al (2002) New WHO histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from China. Cancer 95:420–429PubMedCrossRefGoogle Scholar
  3. 3.
    Okumura M, Ohta M, Miyoshi S et al (2002) Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients. Jpn J Thorac Cardiovasc Surg 50:189–194PubMedCrossRefGoogle Scholar
  4. 4.
    Rieker RJ, Hoegel J, Morresi-Hauf A et al (2002) Histologic classification of thymic epithelial tumors: Comparison of established classification schemes. Int J Cancer 98:900–906PubMedCrossRefGoogle Scholar
  5. 5.
    Strollo DC, Rosado-de-Christenson ML, Jett JR (1997) Primary mediastinal tumors. Part 1: Tumors of the anterior mediastinum. Chest 112:511–522PubMedCrossRefGoogle Scholar
  6. 6.
    Sakai S, Murayama S, Soeda H et al (2002) Differential diagnosis between thymoma and non thymoma by dynamic MR imaging. Acta Radiol 43:262–268PubMedCrossRefGoogle Scholar
  7. 7.
    Armstrong P (2000) Mediastinal and hilar disorders. In: Armstrong P, Wilson AG, Dee P, Hansell DM (eds) Imaging of diseases of the chest. Mosby, LondonGoogle Scholar
  8. 8.
    Verstandig AG, Epstein DM, Miller WT Jr et al (1992) Thymoma-Report of 71 cases and a review. Crit Rev Diagn Imaging 33:201–230PubMedGoogle Scholar
  9. 9.
    Moore KH, McKenzie PR, Kennedy CW, McCaughan BC (2001) Thymoma: Trends over time. Ann Thorac Surg 72:203–207PubMedCrossRefGoogle Scholar
  10. 10.
    Masaoka A, Monden Y, Nakahara K et al (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492PubMedCrossRefGoogle Scholar
  11. 11.
    Regnard JF, Magdeleinat P, Dromer C et al (1996) Prognostic factors and long-term results after thymoma resection: A series of 307 patients. J Thorac Cardiovasc Surg 112:376–384PubMedCrossRefGoogle Scholar
  12. 12.
    Maggi G, Casadio C, Cavallo A et al (1991) Thymoma: Results of 241 operated cases. Ann Thorac Surg 51:152–156PubMedGoogle Scholar
  13. 13.
    Ruffini E, Mancuso M, Oliaro A et al (1997) Recurrence of thymoma: Analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 113:55–63PubMedCrossRefGoogle Scholar
  14. 14.
    Kirschner PA (1990) Reoperation for thymoma: Report of 23 cases. Ann Thorac Surg 49:550–555PubMedCrossRefGoogle Scholar
  15. 15.
    Regnard JF, Zinzindohoue F, Magdeleinat P et al (1997) Results of re-resection for recurrent thymomas. Ann Thorac Surg 64:1593–1598PubMedCrossRefGoogle Scholar
  16. 16.
    Strobel P, Bauer A, Puppe B et al (2004) Tumor recurrence and survival in patient treated for thymomas and thymic squamous cell carcinomas: A retrospective analysis. J Clin Oncol 22:1501–1509PubMedCrossRefGoogle Scholar
  17. 17.
    Blumberg D, Port JL, Weksler B et al (1995) Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg 60:908–913PubMedCrossRefGoogle Scholar
  18. 18.
    Cohen DJ, Ronnigen LD, Graeber GM et al (1984) Management of patients with malignant thymoma. J Thorac Cardiovasc Surg 87:301–307PubMedGoogle Scholar
  19. 19.
    Ciccone A, Rendina EA (2005) Treatment of recurrent thymic tumors. Semin Thorac Cardiovasc Surg 17:27–31PubMedCrossRefGoogle Scholar
  20. 20.
    Wright CD, Kessler KA (2005) Surgical treatment of thymic tumors. Semin Thorac Cardiovasc Surg 17:20–26PubMedCrossRefGoogle Scholar
  21. 21.
    Haniuda M, Kondo R, Numanami H et al (2001) Recurrence of thymoma: Clinicopathological features, reoperation, and outcome. J Surg Oncol 78:183–188PubMedCrossRefGoogle Scholar
  22. 22.
    Okumura M, Shiono H, Inoue M et al (2007) Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to World Health Organization histologic classification system. J Surg Oncol 95:40–44PubMedCrossRefGoogle Scholar
  23. 23.
    Shin DM, Walsh GL, Komaki R et al (1998) A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 129:100–104PubMedGoogle Scholar
  24. 24.
    Loehrer PJ, Kim KM, Aisner SC et al (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma. Final results of an intergroup trial. J Clin Oncol 12:1164–1168PubMedGoogle Scholar
  25. 25.
    Giaccone G, Ardizzoni A, Kirkpatrick A et al (1996) Cisplatin and etoposide combination of chemotherapy for locally advanced or metastatic thymoma: A phase II study of the European organization for research and treatment of lung cancer. J Clin Oncol 14:814–820PubMedGoogle Scholar
  26. 26.
    Evans T, Lynch JT (2005) Role of chemotherapy in the management of advanced thymic tumors. Semin Thorac Cardiovasc Surg 17:41–50PubMedCrossRefGoogle Scholar
  27. 27.
    Ohara K, Tatsuzaki H, Fuji H et al (1998) Radioresponse of thymomas verified with histologic response. Acta Oncologica 37(5):471–474PubMedCrossRefGoogle Scholar
  28. 28.
    Gripp S, Hilgers K, Wurm R et al (1998) Thymoma: Prognostic factors and treatment outcomes. Cancer 83(8):1495–1503PubMedCrossRefGoogle Scholar
  29. 29.
    Kirkove C, Berghmans J, Noel H et al (1992) Dramatic response of recurrent invasive thymoma to high doses of corticosteroids. Clin Oncol (R Coll Radiol) 4:64–66Google Scholar
  30. 30.
    Palmieri G, Lastoria S, Colao A et al (1997) Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med 336:263–265PubMedCrossRefGoogle Scholar
  31. 31.
    Berthaud P, Le Chevalier T, Tursz T (1990) Effectiveness of interleukin-2 in invasive lymphoepithelial thymoma. Lancet 335:1590PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • Piero Zannini
    • 1
  • Giampiero Negri
    • 1
  • Monica Casiraghi
    • 1
  • Luca Ferla
    • 1
  • Paola Ciriaco
    • 1
  1. 1.General Thoracic Surgery UnitUniversity “Vita-Salute” Scientific Institute San Raffaele HospitalMilanItaly

Personalised recommendations